SOFTWARE

July 6, 2020

Heta compiler has been published on GitHub as an OpenSource

(Moscow-06.07.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms. Particularly, it allows combining modules written in different formats like: Heta language code, Excel sheets, JSON, YAML formatted structures, SBML and transforming them into the dynamic models of different formats.

Read more about InSysBio to announce the launch of its new tool Heta compiler

InSysBio to present COVID-19 QSP model further development

PUBLICATION

June 30, 2020

InSysBio continues to move forward in COVID-19 QSP model development. Its aim is to describe virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.

Read more about InSysBio to present COVID-19 QSP model further development

InSysBio to release the new version of Cytocon DB 1.1.6.4

June 12, 2020

We are glad to announce the release of the new version of Cytocon DB 1.1.6.4. The DB was significantly extended with new data due to well-coordinated workflow of Cytocon DB team and its new members. Namely, 54 diseases, 24 tissues, 42 molecules, 24 cells and 3701 concentrations were introduced.

Read more about InSysBio to release the new version of Cytocon DB 1.1.6.4

InSysBio to perform the first step in development of COVID-19 QSP model

June 8, 2020

InSysBio has performed the first step in the direction of development of QSP model of COVID-19 describing virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.

Read more about InSysBio to perform the first step in development of COVID-19 QSP model

InSysBio to present IRT Navigator 3

June 5, 2020

InSysBio presents IRT Navigator 3 which is an application software providing intuitive interface to work with the Immune Response Template Database in accordance with the user’s needs. It supplies the navigation within the schemes and components and efficient development of QSP models based on IRT Database.

Read more about InSysBio to present IRT Navigator 3

InSysBio to announce the launch of QSP model of COVID-19

June 2, 2020

The new open source project to be developed and updated Online

InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its fundamentally new project in response to the ongoing global threat, the open source QSP model of COVID-19. In accordance with its mission, which is to assist pharmaceutical industry to speed up the delivery of the cure to patients, InSysBio team could not stay aside. Thus, the aim of the new project is to develop QSP model of COVID-19 describing virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.

Read more about InSysBio to announce the launch of QSP model of COVID-19

InSysBio innovates its Immune Response Template Database

April 15, 2020

IRT version 3.1.0 acquires some principal upgrades

(Moscow – 15.04.2020) InSysBio is one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling has published the new version of IRT database, one of its core products.

Read more about InSysBio innovates its Immune Response Template Database

InSysBio to announce the release of its new database Cytocon DB 1.1

March 31, 2020

Cytocon DB 1.1 facilitates access of QSP modelers to baseline in vivo data in public domain

(Moscow - 31.03.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, has released its new Cytocon DB 1.1. The name of the database derives from Cell and cYTOkine CONcentrations.

Read more about InSysBio to announce the release of its new database Cytocon DB 1.1

InSysBio presents an enhanced version of its Immune Response Template Database

February 21, 2020

IRT Version 3.0.0 acquires a wide variety of updates and new options

(Moscow – 21.02.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, moves forward to the future.

Read more about InSysBio presents an enhanced version of its Immune Response Template Database

PK/RO simulator for anti-PD-1 mAbs

November 25, 2019

InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP), modeling and simulation for drug development, announced the launch of application ‘PK/RO simulator for anti-PD-1 mAbs’. The application is based on the model allowing to predict pharmacokinetics and target binding in human for therapeutic antibodies against PD-1 receptor.